Literature DB >> 2224144

Patterns of contact phase proteins indicating neuropathy in diabetic patients.

P Meier1, G A Marbet, W Berger, F Duckert, W Friedli.   

Abstract

In 42 outpatients of the diabetology division, coagulation and fibrinolysis variables were determined in order to detect typical patterns of results with which it was possible to discriminate between three groups with different diabetic complications (17: no complication, 7: angiopathy alone, 18: neuropathy with or without other complications). There was a statistically significant discriminatory function involving C1-inhibitor concentration, high molecular weight kininogen coagulant activity and fibrinogen as the most decisive variables. The neuropathy group was appropriately separated from the others with an 81% correct reclassification. Heparin cofactor II, histidine-rich glycoprotein, alpha 2-macroglobulin, pre-kallikrein and factor XII had no discriminative power.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2224144     DOI: 10.1007/bf01744135

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  16 in total

1.  [Rapid physiological coagulation method in determination of fibrinogen].

Authors:  A CLAUSS
Journal:  Acta Haematol       Date:  1957-04       Impact factor: 2.195

2.  Increased concentrations of heparin cofactor II in diabetic patients, and possible effects on thrombin inhibition assay of antithrombin III.

Authors:  J Gram; J Jespersen
Journal:  Clin Chem       Date:  1989-01       Impact factor: 8.327

3.  Kallikrein-kinin system in diabetic patients.

Authors:  S Uehara; S Isogawa; W Sakamoto; A Hirayama
Journal:  Arzneimittelforschung       Date:  1988-05

4.  Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies.

Authors:  C B Laurell
Journal:  Anal Biochem       Date:  1966-04       Impact factor: 3.365

5.  Increased thromboplastic potential in diabetes: a multifactorial phenomenon.

Authors:  M M Landgraf-Leurs; T Ladik; B Smolka; T Bock; W Schramm; M Spannagl; R Landgraf
Journal:  Klin Wochenschr       Date:  1987-07-01

6.  Fifteen coagulation and fibrinolysis parameters in diabetes mellitus and in patients with vasculopathy.

Authors:  M Christe; J Fritschi; B Lämmle; T H Tran; G A Marbet; W Berger; F Duckert
Journal:  Thromb Haemost       Date:  1984-10-31       Impact factor: 5.249

7.  Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor.

Authors:  C F Scott; L D Silver; M Schapira; R W Colman
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

8.  Contact phase of blood coagulation in diabetes mellitus.

Authors:  G M Patrassi; R Vettor; D Padovan; A Girolami
Journal:  Eur J Clin Invest       Date:  1982-08       Impact factor: 4.686

9.  The spatial distribution of fiber loss in diabetic polyneuropathy suggests ischemia.

Authors:  P J Dyck; J L Karnes; P O'Brien; H Okazaki; A Lais; J Engelstad
Journal:  Ann Neurol       Date:  1986-05       Impact factor: 10.422

10.  Heparin cofactor II determination--levels in normals and patients with hereditary antithrombin III deficiency and disseminated intravascular coagulation.

Authors:  T H Tran; F Duckert
Journal:  Thromb Haemost       Date:  1984-10-31       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.